Navigation Links
Angiomax Will Retain Decision Resources' Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI
Date:2/25/2009

Amir Mobasheri. "However, Efient and other emerging drugs such as AstraZeneca's ticagrelor, The Medicines Company's cangrelor and GlaxoSmithKline's Arixtra are not expected to achieve a market share as high as that of Angiomax, largely owing to safety or efficacy concerns."

About the Report

NSTEMI: Finding the Balance between Efficacy and Safety is a DecisionBase 2009 report. DecisionBase 2009 is a decision-support tool that provides in-depth analysis of unmet need, physician expectations of new therapies and commercial dynamics to help pharmaceutical companies optimize their investments in drug development.

The report can be purchased by contacting Decision Resources. Members of the media may request an interview with an analyst.

About Decision Resources

Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Decision Resources                       Decision Resources, Inc.
    Christopher Comfort                      Elizabeth Marshall

'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity
2. Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand
3. Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder
4. New Study Confirms That the Supports Intensity Scale Assessment is Effective in Measuring the Support Needs of People With Intellectual Disability and Making Funding Decisions
5. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
6. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
7. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
8. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
9. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
10. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
11. New Study Shows Proprietary Canola Extract, Dermytol(TM), Produces Pronounced Decrease in Malignant Melanoma Tumor Volume
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... LUNGevity Foundation, the nation,s leading lung ... (FDA) approval of Bristol Myers Squibb,s new immunotherapy ... add another critical new treatment option to fight ... patient,s own immune system to fight cancerous cells. ... patients with squamous cell lung cancer, a population ...
(Date:3/5/2015)... , March 5, 2015 Soligenix, Inc. ... biopharmaceutical company committed to developing products that address unmet ... biodefense, announced today that its President and Chief Executive ... a corporate presentation at the 27 th Annual ... , on Tuesday, March 10, 2015 at 1:00 PM ...
(Date:3/5/2015)... , March 5, 2015 ... System Market by Product (Systems and Disposables), by Type ... Labs , Home and Ambulatory Sites) - Analysis & ... Systems Market is expected to reach $1,107.4 Million by ... to grow at a CAGR of 4.5% during the ...
Breaking Medicine Technology:LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4
... Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: ... Cephalon, Inc. (NASDAQ: CEPH): In a letter ... stated that it "is presently undertaking a review of ... is focused on maximizing Cephalon shareholder value."  We know ...
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... to discuss first quarter 2011 financial results, as well as ... at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time; 2:00 ... ended March 31, 2011 will be released earlier that day. ...
Cached Medicine Technology:Valeant Pharmaceuticals Responds to Cephalon Board's Letter 2Valeant Pharmaceuticals Responds to Cephalon Board's Letter 3Valeant Pharmaceuticals Responds to Cephalon Board's Letter 4Onyx Pharmaceuticals Announces First Quarter 2011 Financial Results Teleconference and Webcast 2
(Date:3/6/2015)... 2015 Magellan Rx Management’s 2014 Medical ... for key trends and statistics on one of the ... from Magellan Rx Management will discuss key findings from ... Hidden Specialty Drug Spend,” a complimentary March 19 webinar, ... Specialty drug spend makes up more than a quarter ...
(Date:3/6/2015)... 06, 2015 The Gluten-Free Certification ... Association, is pleased to announce that Dufflet Pastries, ... has expanded their product line of gluten-free treats ... scrumptious and as satisfying as any of their ... and never contains hydrogenated fats or oils, artificial ...
(Date:3/6/2015)... Dr. Mark Sowell recently returned from leading ... Offering programs for advanced education in the field of dentistry, ... , As a visiting faculty member of this prestigious institution, ... time he visits Spear Education to participate in a specialized ... are training only the top 10% and those willing to ...
(Date:3/5/2015)... From Oct. 5-10, Mumbai, India will serve ... . These dates include the following activities:, ... October 6: Conference Day 1, ending with a ... Day 2, ending with Local Entertainment and Dinner , ... other Materials Meetings , October 9-10: Textiles in ...
(Date:3/5/2015)... A Bakersfield, Calif. state court jury returned a verdict this ... Coleen M. Perry a total of $5.7 million for damages ... sling device, manufactured by Ethicon, Inc., a subsidiary of Johnson ... Wagstaff & Cartmell in Kansas City, Mo., was ... Freese and Tim Goss of Freese & Goss ...
Breaking Medicine News(10 mins):Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2Health News:Textile Exchange Announces the 2015 Textile Sustainability Conference Dates 2Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2
... Commercial Grade Cardio Bike Created Specifically for Middle ... Fitness(R), the leading supplier and developer of interactive ... the S3 Upright Youth Bike, a virtual-reality cardio ... The S3 Youth Bike is the only commercial-grade ...
... Uses BVS 5.6 Onboard Software to Navigate the Safest, Most ... Hope, Healing and Hospital Services to the World,s PoorSUNNYVALE, Calif., ... (AWT) today announced that Mercy Ships , the leader ... services to the poor, recently used the latest version of ...
... from a life of creative writings and author,s ... Randy Patterson has spent the last three ... and extremely rare cancer called Burkitt,s Lymphoma. After ... taps, mounting financial debt, and constant worry for ...
... Corp. ("SXC" or the "Company") (NASDAQ: SXCI , ... announces that Standard and Poor,s (S&P) has added the Company ... Quarterly S&P/TSX Composite Index review. The change will be effective ... are very pleased with our inclusion on the index," said ...
... 16 Stereotaxis, Inc. (Nasdaq: STXS ) today ... Valley Bank, a member company of SVB Financial Group (Nasdaq: ... matures on March 31, 2010, the Company can borrow up ... credit, combined with our existing cash position and other financing ...
... To commemorate Brain Awareness Week, Posit Science today ... consumers are still spending their money on keeping their ... brain fitness industry to growth in the publication of ... that certain types of cognitive training yields benefits. ...
Cached Medicine News:Health News:Expresso Fitness(R) Launches First Virtual Reality Cardio Bike for Kids 2Health News:Applied Weather Technology Guides Mercy Ships With Latest BVS Marine Voyage Optimization Software 2Health News:Applied Weather Technology Guides Mercy Ships With Latest BVS Marine Voyage Optimization Software 3Health News:Applied Weather Technology Guides Mercy Ships With Latest BVS Marine Voyage Optimization Software 4Health News:Trinadgey Launches to Sci-Fi Lovers via New Online Portal Trinadgey.com 2Health News:SXC Health Solutions Added to S&P/TSX Composite Index 2Health News:Stereotaxis Extends Its Credit Facility With Silicon Valley Bank 2Health News:Stereotaxis Extends Its Credit Facility With Silicon Valley Bank 3Health News:Brain Fitness Industry Growth Driven By Science 2Health News:Brain Fitness Industry Growth Driven By Science 3
GelPort hand access laparoscopy combines the patient outcomes of minimally invasive surgery with the speed and precision of open surgery....
... Systems non-adhesive sealing method maintains ... Surgrery (HALS) procedures, allowing the ... palpate throughout. Because HALS requires ... cm, patients experience less trauma ...
... a Hand Assisted Laparoscopic Surgery (HALS) device ... hand may facilitate the procedure, and for ... in colorectal, urological and general surgical procedures. ... of pneumoperitoneum and abdominal access for the ...
... The SleepStyle 200 series offers a ... CPAP models. The design delivers therapy ... Performance features promote results in commercial ... The strongest differentiator in the SleepStyle ...
Medicine Products: